Product Title: Utilizing Effective Risk Communication in COVID-19 (Original PDF from Publisher)
Format:
Publisher PDF, File Size = 5.90 MB
Overview (Details, Topics and Speakers):
This book demonstrates how a novel decision-aid, called a Benefit-Risk Characterization Theater (BRCT), can be used to:
· Significantly improve accurate communication of health risks from exposure to COVID-19; and
· Assess how to best contain and control COVID-19.
To date, there have been far-reaching ramifications based on ineffective risk communication when clarifying these health endpoints.
A BRCT is a familiar, theatrical chart representation of 1,000 people, with the risks and benefits shown by blackened seats. Since health outcomes can easily be put into such a chart, we show how BRCTs can be used objectively by professionals, the media and lay people. It allows characterization and communication of health benefits and risks of COVID-19 treatment and containment in an undemanding and straightforward way.
BRCTs have been successfully used to assist patients in determining:
· Their level of acceptable risk of various medical interventions;
· If the benefits of intervention outweigh the risks;
· Who should make the final decision regarding medical intervention; and
· Whether the decision is evidence-based.
Written by experts in the field, this book fills in a gap in communication between the medical community, the public and patients. It also provides an area of expertise in communication that is beneficial for medical providers and medical students.
Product Details
- Publisher: Springer International Publishing; August 13, 2021
- Language: English
- ISBN: 978-3030745202
- ISBN: 9783030745202
- eText ISBN: 9783030745219
Delivery Method
the Utilizing Effective Risk Communication in COVID-19 (Original PDF from Publisher) course/book will be provided for customer as download link. download link has NO Expiry and can be used anytime.
Contact Us
contact us to our email at support@med-cme.com or fill in the form below:
Reviews
There are no reviews yet.